15 April 2024 - The HTA Review Reference Committee is finalising its report and recommendations to the Australian Government having ...
15 April 2024 - The review is due to be completed by 15 April 2024 (today). ...
19 March 2024 - Rare Disorders NZ is very concerned that Pharmac will not extend access to life-saving medicines for ...
6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...
29 February 2024 - Last year, CADTH communicated several improvements to our drug reimbursement review program, including a Lean review ...
15 February 2024 - The draft paper 'Emerging Health Technologies' developed to support the deliberations of the HTA Review Reference ...
6 February 2024 - Access to the HTA Review Consultation 2 online survey is now available on the Office of ...
25 January 2024 - The Options paper for Consultation 2 is now available on the Office of Health Technology Assessment consultation ...
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...
18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...
16 January 2024 - In 2023, EMA recommended 77 medicines for marketing authorisation. ...
4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...
8 December 2023 - The agenda for the HTA Review Reference Committee meeting (meeting 29) held on 1 December 2023 is ...
1 December 2023 - To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input ...
21 November 2023 - Most people probably assume that all prescription drugs on the US market have been proven effective in ...